Intact Therapeutics
Belmont
About Intact Therapeutics
Intact Therapeutics is a next generation local drug delivery for gastrointestinal diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $645.0K
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2021)
- Website: intacttherapeutics.com
- Phone: [email protected]
Industries & Categories
Delivery, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/intact-therapeutics-80406 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.